Favorable Selection In MA Linked To Billions In Overpayments
 â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â
Wednesday, September 6, 2023 | The Latest Research, Commentary, And News
From Health Affairs
Dear John,
We are excited to publish the first episode of our new health equity
podcast, Research and Justice For All
<[link removed]"favorable selection into MA led to underpayments for
counties with lower MA penetration and overpayments to counties with
higher MA penetration."
At the same time, MA enrollment has shifted to countries with higher MA
penetration, ultimately leading to overpayments to MA plans averaging
$9.3 billion per year between 2017 and 2020.
Ryan and coauthors conclude that benchmark-setting reforms could
"mitigate the impact of favorable selection in MA" and avoid
overpayment.
Read More
<[link removed]"Private Sector Solutions for Health Equity," is
sponsored by CVS Health and cohosted by Sree Chaguturu, Chief Medical
Officer (CVS Health) and Joneigh Khaldun, Chief Health Equity Officer
(CVS Health).
In the first episode of Research and Justice For All, Chaguturu and
Khaldun interview Thomas Sequist from Massachusetts General Brigham on
the important role of health and hospital systems in driving health
equity in the US.
Listen Here
<[link removed]'s Time For A New Season Of Episode-Based Payment
<[link removed]' Rob Lott and Chris Fleming discuss the Biden
administration's announcement regarding the first 10 drugs selected for
Medicare price negotiation.
Â
[link removed]
